Hayat Pharmaceutical Industries CoAMM:HPIC 76 Pretax Margin % is 8.96% as of Mar. 2026, which is 63% below its 10-year median of 23.95. GuruFocus rates AMM:HPIC with a GF Score™ of 76/100 and a GF Value™ of JOD2.74 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 953 Drug Manufacturers companies, Hayat Pharmaceutical Industries Co ranks better than 70.3% on this metric.
The historical rank and industry rank for Hayat Pharmaceutical Industries Co's Pretax Margin % or its related term are showing as below:
AMM:HPIC'
s Pretax Margin % Range Over the Past 10 Years
Min: 15.15 Med: 23.95 Max: 26.12
Current: 15.15
AMM:HPIC's Pretax Margin % is ranked better than 70.3% of 953
companies
in the Drug Manufacturers industry
Industry Median: 7.3
vs AMM:HPIC: 15.15
Hayat Pharmaceutical Industries Co (AMM:HPIC) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Hayat Pharmaceutical Industries Co Pretax Margin % Related Terms
Hayat Pharmaceutical Industries Co Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hayat Pharmaceutical Industries Co Pretax Margin % Chart
AMM:HPIC vs ZTS, UTHR, VTRS: Pretax Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Hayat Pharmaceutical Industries Co's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hayat Pharmaceutical Industries Co Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hayat Pharmaceutical Industries Co's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Hayat Pharmaceutical Industries Co's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hayat Pharmaceutical Industries Co (AMM:HPIC) has a Pretax Margin % of 8.96% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Hayat Pharmaceutical Industries Co and its competitors. This is 63% below median its historical median of 23.95. Over the past decade, Hayat Pharmaceutical Industries Co's Pretax Margin % has ranged from 15.15 to 26.12. According to the industry distribution chart, Hayat Pharmaceutical Industries Co ranks #283 out of 953 companies in the Drug Manufacturers industry, placing it in the top 29.7%.
Is Hayat Pharmaceutical Industries Co's Pretax Margin % too high?
Hayat Pharmaceutical Industries Co's current Pretax Margin % of 8.96% is 63% below median its 10-year median of 23.95. Over the past 10 years, this metric has ranged from a low of 15.15 to a high of 26.12. The Drug Manufacturers industry median Pretax Margin % is 7.30. Hayat Pharmaceutical Industries Co's value of 8.96% is 22.7% above this industry median. Based on the distribution chart, Hayat Pharmaceutical Industries Co ranks #283 out of 953 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Hayat Pharmaceutical Industries Co has a GF Score™ of 76/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hayat Pharmaceutical Industries Co's Pretax Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Hayat Pharmaceutical Industries Co ranks #283 out of 953 companies for Pretax Margin %. This puts Hayat Pharmaceutical Industries Co in the upper half of its industry. The industry median Pretax Margin % is 7.30. Hayat Pharmaceutical Industries Co's value of 8.96% is 22.7% above this benchmark. Historically, Hayat Pharmaceutical Industries Co's own Pretax Margin % has ranged from 15.15 to 26.12 over the past decade. While the company's 10-year median is 23.95 vs. the industry median of 7.30, Hayat Pharmaceutical Industries Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.30, based on 953 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hayat Pharmaceutical Industries Co's current Pretax Margin % of 8.96% is 22.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Hayat Pharmaceutical Industries Co and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hayat Pharmaceutical Industries Co's current Pretax Margin % is 8.96%, which is 63% below median its own 10-year median of 23.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hayat Pharmaceutical Industries Co stock overvalued right now?
Based on GuruFocus' analysis, Hayat Pharmaceutical Industries Co (AMM:HPIC) is currently considered Modestly Overvalued. The stock's GF Value™ is JOD2.74, compared to a current price of JOD3.13 — trading 14.2% above its estimated fair value. The current Pretax Margin % is 8.96%, which is 63% below median its 10-year median of 23.95 and 22.7% above the Drug Manufacturers industry median of 7.30. Hayat Pharmaceutical Industries Co's overall GF Score™ is 76/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Hayat Pharmaceutical Industries Co (AMM:HPIC), the current Pretax Margin % is 8.96% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hayat Pharmaceutical Industries Co (AMM:HPIC) Overvalued in 2026?
Based on GuruFocus' analysis, Hayat Pharmaceutical Industries Co stock appears to be overvalued.
The current stock price of JOD3.13 is trading 14.2% above its estimated GF Value™ of JOD2.74.
GuruFocus considers Hayat Pharmaceutical Industries Co to be Modestly Overvalued.
Key valuation signals for AMM:HPIC:
Pretax Margin %: 8.96% (63% below median its 10-year median of 23.95)
GF Value™: JOD2.74 vs. price of JOD3.13 (14.2% above fair value)
Industry Position: 22.7% above the Drug Manufacturers median (#283 of 953)
No single metric tells the full story. See the AMM:HPIC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hayat Pharmaceutical Industries Co Business Description
Hayat Pharmaceutical Industries Co is a Jordan based pharmaceutical manufacturing company. The princapal activity is producing human and veterinary medicines in all its forms and medical stickers and stockings, in addition to the production of medical supplies, body care lotions, cosmetics, sutures and initiating marketing campgains as well as import and export operations. Its products include Cardiovascular system, Infectious disease, Dermatology, Gastrointestinal system, Inner Ear & Balance, Men's Health, Neurology, Vitamins & Supplements, Women's Health, and Respiratory system. The operations business operating within one geographic sector which is the Hashemite Kingdom of Jordan.
76GF Score
Get the complete analysis for AMM:HPIC
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMM:HPIC has been successfully added to your 
